Adam King
Senior Director of Regulatory Affairs & Service Ar
adminisration
 PharmaLex GmbH
Germany
Biography
Dr. Adam King has been Senior Director of Regulatory Affairs & Service Area of PharmaLex GmbH since August 2017. In the new role, Dr. King work on regulatory activities related to mergers and acquisitions, it is reported today. Dr. King has more than 30 years' experience of working in the pharmaceutical industry to PharmaLex. During that time he spent more than 18 years in regulatory affairs, with a focus on radiopharmaceuticals, regulatory strategy development and the oversight of regulatory affairs CMC programmes. His most recent experiences include leading a team of regulatory consultants to complete a CMC compliance project and he has also been R&D lead for the design and implementation of an electronic document management system, publishing tools into a combined R&D and manufacturing environment.
Research Interest
Pharmaceutical
